Bacterial cell wall components regulate adipokine secretion from visceral adipocytes

Abstract

Recent studies suggest a relationship between intestinal microbiota and metabolic syndromes; however, the underlying mechanism remains unclear. To clarify this issue, we assessed the effects of bacterial cell wall components on adiponectin, leptin and resistin secretion from rat visceral adipocytes in vitro. We also measured the relative population of Firmicutes and Bacteroidetes in fecal microbiota and the amount of fecal mucin as an intestinal barrier function, when mice were fed a high-fat diet. In the present study, we demonstrated that bacterial cell wall components affect the secretion of adipokines, depending on the presence of antigens from gram-positive or gram-negative bacteria. Lipopolysaccharide markedly inhibited adiponectin, leptin, and resistin secretion, whereas peptidoglycan increased adiponectin secretion and decreased resistin secretion in vitro. In vivo experiments showed that the high-fat diet increased the population of Firmicutes and decreased that of Bacteroidetes. In contrast, the high-fat diet downregulated the stool output and fecal mucin content. These results demonstrate that bacterial cell wall components affect the onset of metabolic syndromes by mediating the secretion of adipokines from visceral adipose tissue. Furthermore, we believe that metabolic endotoxemia is not due to the increasing dominance of gram-negative bacteria, Bacteroidetes, but due to the depression of intestinal barrier function.

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

“…The present studies observed a strong correlation between the Faecalibacterium and serum adiponectin in MS patients. Studies suggest that gram positive cell wall components stimulate adiponectin production (Taira et al, 2015). Whether the presence of Faecalibacterium in the gut microbiome has a direct or indirect role in modulation of serum adiponectin warrants further investigation.…”

Gut–liver axis, nutrition, and non-alcoholic fatty liver disease

“…It has been shown that LPS acts as a master switch to control adipose tissue metabolism both in vivo and ex vivo by blocking cannabinoiddriven adipogenesis [10]. Additionally, LPS inhibited the secretion of adipokines, specifically adiponectin, from the visceral adipose tissue [22], that may affect the onset of metabolic syndrome. Further, it has been reported that decreased production of N -acylethanolamines, an important mediators of metabolic homeostasis and inflammation, in the adipose tissue induced intestinal barrier dysfunction and dysbiosis of the gut microbiota, which in turn participates in the metabolic alterations observed in the adipose tissue [23].…”

The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease

“…Regarding other TLRs implicated in NAFLD pathogenesis, TLR2 is also a cell surface receptor, which is involved in the recognition of a wide range of pathogen-associated molecular patterns (PAMPs) including peptidoglycan, a component of the cell surface of Gram-positive bacteria [ 75 ]. These subtypes of bacteria include Firmicutes, whose increase has been reported in animal models and humans subjected to a high-fat diet [ 99 ]. Furthermore, this dysbiosis has also been associated with NAFLD [ 100 ].…”